The authors have noticed the data in the original Table 4 of this article do not match the values reported in the text. The values in the original Table 4 do not correspond to the overall vaccine effectiveness calculations; but rather, they correspond to a subset analysis of people who had only received one dose of the 23-valent pneumococcal polysaccharide vaccine.
Table 4.
Age- and gender- adjusted vaccine effectiveness of 23-valent pneumococcal polysaccharide vaccine (PPV23) against invasive pneumococcal disease in people ≥60 in Germany. 95% CI shows the lower and upper bounds of the 95% confidence interval of the vaccine effectiveness estimate.
| All | vaccinated <2 years prior to IPD |
vaccinated between 2 and 4 years prior to IPD |
vaccinated ≥5 years prior to IPD |
Age 60-69 |
Age 70-79 |
Age ≥80 |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VE (%) | 95% CI (%) | VE (%) | 95% CI (%) | VE (%) | 95% CI (%) | VE (%) | 95% CI (%) | VE (%) | 95% CI (%) | VE (%) | 95% CI (%) | VE (%) | 95% CI (%) | |
| PPV23 serotypes | 36 | 10,54 | -20 | -130,34 | 56 | 20,76 | 47 | 17,66 | 71 | 42,86 | 28 | -27, 58 | 12 | -53,49 |
| PPV23 serotypes except 3 | 63 | 49,74 | 49 | 12,71 | 66 | 37,82 | 69 | 50,81 | 67 | 33, 85 | 63 | 38, 79 | 60 | 32,77 |
| PPV23 serotypes except 3 and 8 | 58 | 40,70 | 52 | 16,74 | 48 | 3,73 | 65 | 42,79 | 62 | 21,83 | 59 | 28, 78 | 51 | 16,72 |
| PPV23-nonPCV13 serotypes | 59 | 42,71 | 38 | -7,66 | 67 | 36,84 | 65 | 42,79 | 78 | 50,92 | 54 | 21, 74 | 50 | 12,72 |
| Serotype 3 | -117 | -208,-53 | -179 | -384,-58 | -60 | -201,19 | -106 | -229,-26 | -1 | -117, 56 | -159 | -361, -45 | -176 | -390, -55 |
The changes to Table 4 do not impact the final analysis or conclusions of the manuscript, but there are several places in the text where there is a discrepancy between the corrected values in the table and in the original text of the manuscript. Please use the values in this corrected table in place of the values listed in the text.
The correct Table 4 is presented below: